Subject Index
A
abscess 119 absolute ethanol 387
acute lymphoblastic leukemia, see leukemia acute myeloid leukemia, see leukemia adrenal gland metastases 266 – ipsilateral 44
AIDS-related lymphoma 344
American Joint Committee on Cancer (AJCC) 104 – staging 105
angiography 75–87 – aftercare 80 – bone metastases 316 – collecting duct carcinoma 181 – evaluation of renal masses 81 – fi nishing the procedure 80 – history 75
– intravascular contrast media 78 – management of renal masses 81 – preparation 78
– renal cell carcinoma 110 – renal embolization 80 – selective renal angiography 78 – technique 79
– transitional cell carcinoma 137 angiomyolipoma
– CT 40
– MR imaging 53, 62 – pediatric 365
– sarcomatoid transformation 150 – tuberous sclerosis 235
– ultrasound 22, 107 angiosarcoma 152
avascular renal cell carcinoma – histopathology 225
B
Balkan endemic nephropathy 126 ball-like mass 195
beam-hardening effect 160
Beckwith-Wiedemann syndrome 352, 355
Bellini duct carcinoma, see collecting duct carcinoma bilateral renal cell carcinoma 234
Birt-Hogg-Dubé syndrome – BHD gene 12
– clinical features 251 – folliculin 251 – genetics 251
– imaging 251 – management 251 biopsy 371–375 – complications 375
– inderterminate cystic renal mass 165 – indications 372
– lymphoma 333 – results 374
– small renal neoplasms 213 – technique 373
bladder metastases 281 bone metastases 309–320 – angiography 316 – bone scan 316 – CT 315
– fl ow-void sign 315 – MR imaging 315 – pathophysiology 310 – pediatric metastases 317 – PET 316
– plain radiograph 310 – transarterial embolization 391
bone metastasizing renal tumor of childhood, see renal cell sarcoma
bone scan
– bone metastases 316 bone scintigraphy, see bone scan
Bosniak classifi cation 19, 24, 34, 54, 161, 229, 373, 417 brain metastases 285
breast metastases 265
C
calcifi cation
– bone metastases 314 – renal cell carcinoma 231 calibrated microspheres 386 carbon dioxide 78
cataract 150
cauda equine metastases 290 chemical shift imaging 61 chloroma, see myeloid sarcoma chondrosarcoma 153
chromophobe renal cell carcinoma – CT 39
– histopathology 6, 221
chronic lymphoblastic leukemia, see leukemia clear cell renal cell carcinoma
– histopathology 220
clear cell sarcoma 317, 358
c-MET proto-oncogene 248 coils 388
collecting duct carcinoma 171–185 – angiography 181
– clinical features 172 – CT 39, 177 – cytogenetics 176 – differential diagnosis 182 – excretory urography 177 – gross morphology 174 – histopathology 7, 173, 221 – immunohistochemistry 175 – microscopic fi ndings 174 – MR imaging 180 – pathologic criteria 176 – periodic acid-Schiff (PAS) 176 – prognosis 183
– sickle cell trait (SCT) 173 – treatment 183
– Ulex europaeus agglutinin-I (UEA-I) 172, 175 – ultrasound 177
colonic metastases 278 computed tomography, see CT conventional renal cell carcinoma – CT 36
– histopathology 2 – MR imaging 54 CT 29–49
– advantages of multidetector CT 31 – angiomyolipoma 40
– bone metastases 315
– characterization of renal masses 33 – chromophobe renal cell carcinoma 39 – collecting duct carcinoma 39, 177 – conventional renal cell carcinoma 36 – cystic lesions 34, 159
– detection of renal masses 31 – lymphoma 42, 323
– metastases 42
– nephron-sparing surgery 47 – oncocytoma 39
– papillary renal cell carcinoma 39 – phases of renal enhancement 29 – post processing techniques 31 – renal cell carcinoma 110 – renal sinus neoplasms 189 – signifi cant enhancement 33 – small renal neoplasms 206 – staging 43
– – distant metastases 46 – – ipsilateral adrenal gland 44 – – local extension 46
– – perinephric spread of tumor 44 – – regional lymph node metastases 45 – – tumors confi ned within the renal capsule 43 – – venous spread of tumor 45
– techniques 29
– transitional cell carcinoma 42, 132 cyanoacrylate 387
cystic nephroma 365
cystic partially differentiated nephroblastoma 365 cystic renal masses 116, 159–169
– acquired cystic disease of the kidney 229
– biopsy in inderterminate cystic renal mass 165 – Bosniak classifi cation 19, 116, 161
– calyceal diverticulum 167
– changes in renal cell carcinoma 227 – comparing CT to MR imaging 164 – CT 34, 159
– Doppler 19
– hairline thin septa 160 – hairline thin wall 160 – histopathology 8 – hyperdense cyst 161
– laparoscopic partial nephrectomy 416 – localized cystic disease of the kidney 166 – lymphoma 327
– MR imaging 54, 159
– multilocular cystic nephroma 166
– multilocular cystic renal cell carcinoma 229 – polycystic kidney disease 229
– renal mass enhancement 160 – ultrasound 19
cytokeratin 172
D
Dandy-Walker malformation 150 de-enhancement 34
detection – CT 16 – MR imaging 52 – ultrasound 15
diaphragmatic metastases 298 differential diagnosis
– collecting duct carcinoma 182
– mesenchymal tumors of the renal sinus 194 dimercaptosuccinic acid nuclear scan 416 Drash syndrome 355
duodenal metastases 277
E
embolization 80
endobronchial metastases 260
enhanced fast gradient-recalled echo (EFGRE) 63 epidural space metastases 291
esophageal metastases 275
excretory urography, see intravenous urography extramedullary plasmacytoma, see plasmacytoma extraosseous Ewing sarcoma/primitive neuroectodermal
tumor 154
eye and adnexa metastases 293
F
familial renal cancer 254 familial renal oncocytoma 252 – clinical features 252 – genetics 252 – imaging 252 – management 252
fast low-angle shot (FLASH) 61
fast spoiled gradient-recalled (FSPGR) 61 fat
– renal cell carcinoma 233 F-fl uoro-deoxy-glucose (FDG) 89 fi brosarcoma 153
fi eld of view (FOV) 52 fi ne-needle aspiration – small renal neoplasms 213 fl ow-void sign 315
folliculin 251
Fuhrman grade 3, 243, 250 fumarate hydratase gene 250
G
gadolinium 52, 78, 159 gallbladder metastases 274 gastric metastases 277 gelatin sponge 386 – pledgets 388
glucose transporter 1 (GLUT-1) 90 granular renal cell carcinoma – histopathology 9
granulocytic sarcoma, see myeloid sarcoma
H
hairline thin septa 160 hairline thin wall 160
half-Fourier acquisition single-shot turbo spin echo (HASTE) 61, 110, 160
hamartin 240
heart and pericardium metastases 261 hemangiopericytoma
– renal sinus 193 hemihypertrophy 355 hepatic meatastases 265
hepatocyte growth factor (HGF) receptor 240 hereditary leiomyoma renal cell carcinoma 249 – clinical features 249
– fumarate hydratase gene 250 – genetics 250
– imaging 250 – management 250
hereditary papillary renal cancer 248 – clinical features 248
– c-MET proto-oncogene 248 – genetics 248
– imaging 249 – management 249
hereditary renal cancer 239–256 – Birt-Hogg-Dubé syndrome 251 – familial renal cancer 254 – familial renal oncocytoma 252
– hereditary leiomyoma renal cell carcinoma 249 – hereditary papillary renal cancer 248
– histopathology 240
– medullary carcinoma of kidney 253 – translocation of chromosome 3 254 – tuberous sclerosis 253
– von Hippel-Lindau disease 241
histopathology – classifi cation 1–14
– – chromophobe renal cell carcinoma 6 – – clear renal cell carcinoma 2 – – collecting duct carcinoma 7, 173 – – cystic renal cell carcinoma 8 – – cytology 11
– – genetic and molecular events in renal cell carcinoma 11 – – granular renal cell carcinoma 9
– – Mainz classifi cation 1 – – medullary carcinoma 9 – – papillary renal cell carcinoma 4 – – sarcomatoid renal cell carcinoma 8
– – World Health Organization (WHO) classifi cation 1 – small renal neoplasms 203
– unusual kidney cancers 219 – – avascular renal cell carcinoma 225 – – chromophobe cell renal cell carcinoma 221 – – classifi cation 219
– – clear cell renal cell carcinoma 220 – – collecting duct renal cell carcinoma 221 – – hypovascular renal cell carcinoma 225 – – infi ltrative growth pattern 225 – – medullary renal cell carcinoma 223 – – papillary renal cell carcinoma 221 – – sarcomatoid renal cell carcinoma 225 Hodgkin disease 340
– renal sinus 333 – scaffolding 340
Homer-Wright rosettes 154
Hornstein-Knickenberg syndrome 251 hyperdense cyst 161
hypovascular renal cell carcinoma – histopathology 225
hypoxia inducible factor- α (HIFα) 243
I
imaging-guided biopsy, see biopsy inferior vena cava involvement – CT 45
– Doppler 26 – MR imaging 65–67 – ultrasound 26
intraoperative tumor evaluation – ultrasound 26
intravenous pyelogram (IVP) – calyceal diverticulum 167 intravenous urography (IVU) – collecting duct carcinoma 177 – renal cell carcinoma 106 – renal sinus neoplasms 188 – transitional cell carcinoma 127 iodinated contrast 78
L
laparoscopic partial nephrectomy (LPS) 415–426 – challenges 423
– contraindications 416
– cystoscopy stent placement and positioning 418
laparoscopic partial nephrectomy (LPS) (continued) – full laparoscopic techniques 418
– hand-assisted laparoscopic partial nephrectomy 423 – indications 415
– intraoperative ultrasound 417 – preoperative evaluation 416 – – cystic tumor 416 – – pseudotumor 416 – – solid tumor 417 – results 424
– retroperitoneal approach 422 – transperitoneal approach 418 – – dissection of the left kidney 419 – – dissection of the right kidney 420
– – identifying the tumor and planning the excision 421 leiomyosarcoma 146
– renal sinus 193 leukemia 337 – pediatric 362 lingual metastases 296 liposarcoma 148 local extension – CT 46
localized cystic disease of the kidney 166 local recurrence 301
lung metastases 258 lymph node metastases 284 – regional 45
lymphoma 321–335
– AIDS-related lymphoma 344 – CT 42, 323
– cystic mass 327
– direct extension from retroperitoneal lymphoma 328
– image-guided biopsy 333 – MR imaging 323 – multiple renal masses 325 – nephromegaly 331 – pediatric 360
– perinephric disease 328 – PET 323
– radiologic-pathologic correlation 323 – renal sinus 199, 333
– secondary versus primary 321 – solitary mass 327
– ultrasound 23, 323
lymphoproliferative neoplasms 337–349 – leukemia 337
– multiple myeloma 344 – myeloid sarcoma 339 – plasmacytoma 344
– post-transplantation renal allograft lymphoproliferative disorder 342
– Waldenström macroglobulinemia 344
M
magnetic resonance imaging, see MR imaging Mainz classifi cation 1
malignant fi brous histiocytoma 153 malignant hemangiopericytoma 152 malignant mesenchymoma 153
maximum intensity projection (MIP) – MR imaging 64
– nephron-sparing surgery 406 – transitional cell carcinoma 132 measurable enhancement 161 medullary renal cell carcinoma – clinical features 253 – genetics 253 – histopathology 9, 223 – imaging 253 – management 253 – pediatric 359
mesoblastic nephroma 362 metanephric adenoma 366 metastases 257–308 – adrenal gland 266 – bladder 281
– bone metastases 309–320 – brain 285
– breast 265 – cauda equina 290 – clinical features 258 – colon 278
– diaphragm 298 – duodenum 277 – endobronchus 260 – epidural space 291 – esophagus 275 – eye and adnexa 293 – gallbladder 274
– heart and pericardium 261 – kidney 273
– liver 265 – lung 258 – lymph node 284 – nose and sinuses 295 – ovary 282
– pancreas 270 – parotid gland 291 – pathophysiology 258 – peritoneum 275 – pleura 260 – prostate 281 – renal sinus 200 – skeletal muscle 298 – skin 298
– small intestine 278 – spinal cord 288 – spleen 269
– spontaneous regression 258 – staging 46
– stomach 277 – thyroid gland 296 – tongue 296 microcephalus 150 MR imaging 51–74 – bone metastases 315 – collecting duct carcinoma 180 – cystic renal mass 159
– fl ow-related vascular MR imaging 67 – functional MR imaging 64
– lesion characterization 53
– lesion detection 52
MR imaging (continued) – localizer images 61 – lymphoma 323
– MR angiography (MRA) 64 – MR urography (MRU) 68 – MR venography (MRV) 66 – pre-contrast imaging 63 – post-contrast imaging 63 – post-therapy imaging 59 – protocol 61
– renal cell carcinoma 110 – renal sinus neoplasms 189 – small renal neoplasms 212 – staging 56
– subtraction imaging 64 – T1-weighted images 61 – T2-weighted images 62 – technical considerations 52 – therapy planning 58
– transitional cell carcinoma 137 MR angiography (MRA) 64 MR urography (MRU) 68 – transitional cell carcinoma 137 MR venography (MRV) 66, 111 multilocular cystic renal tumor 365
multilocular cystic nephroma (MLCN) 120, 166 – renal sinus 195
multiplanar 2D gradient echo 61 multiple myeloma 344
multiple renal cell carcinoma 234 myeloid sarcoma 339
N
N-butyl-cyanoacrylate, see cyanoacrylate nephrogenic rests and nephroblastomatosis 355 nephron-sparing surgery 398–402
– complications 400 – CT 47
– indications 398
– laparoscopic partial nephrectomy 415–426 – patient outcome 401
– preoperative imaging 402–413 – surgical procedures 398
– von Hippel-Lindau syndrome 246 neuroblastoma 362
non-Hodgkin lymphoma, see lymphoma non-spherical polyvinyl alcohol particles 386 nose and sinuses metastases 295
O
oncocalyx 128 oncocytoma 119 – CT 39 – familial 252 – metastasizing 241 – oncocytosis 241, 252 – spoke wheel 120 – ultrasound 22
ossifying renal tumor of infancy 363 osteosarcoma 152
ovarian metastases 282
P
pancreatic metastases 270 papillary renal cell carcinoma – CT 39
– histopathology 4, 221 parotid gland metastases 291 partial nephrectomy 58 pathology, see histopathology pediatric kidney tumors 351–369 – angiomyolipoma 365
– bone metastases 317 – clear cell sarcoma 358 – leukemia 362 – lymphoma 360
– mesoblastic nephroma 362 – metanephric adenoma 366 – multilocular cystic renal tumor 365
– nephrogenic rests and nephroblastomatosis 355 – neuroblastoma 362
– ossifying renal tumor of infancy 363 – renal cell carcinoma 358
– renal medullary cell carcinoma 359 – rhabdoid tumor 357
– Wilms tumor 351 perceived enhancement 161 percutaneous biopsy, see biopsy perinephric spread of tumor – CT 44
periodic acid-Schiff (PAS) 176 peritoneal metastases 275 Perlman syndrome 355 PET/CT 89–101 – acquisition 90 – bone metastases 316 – clinical experience 93 – diagnosis 93 – lymphoma 323 – objective 92 – outlook 98
– patient preparation 91 – protocol 91
– quantifi cation 90 – renal cell carcinoma 116 – staging 96
– standardized uptake value (SUV) 91 – technique 90
– uptake mechanism 90 plain radiographs – bone metastases 310 – renal cell carcinoma 105 plasmacytoma 344 pleural metastases 260 polyvinyl acetate 388
polyvinyl alcohol particle (PVA) spheres 387 positron emission tomography, see PET/CT
post-transplantation renal allograft lymphoproliferative disorder 342
preoperative navigation of nephron-sparing surgery 402–413
– clinical applications 409
– intraarterial 3D CT angiography 408
– multiphasic contrast-enhanced CT 402
preoperative navigation of nephron-sparing surgery (continued) – overview 402
– relationship to collecting system 411 – renal position 409
– three-dimensional CT 404 – tumor location and extension 411 – vascular anatomy 409
preoperative tumor staging – ultrasound 26
primitive neuroectodermal tumor (PNET) 154 prognosis
– collecting duct carcinoma 183 – renal cell carcinoma
– – Fuhrman grade 3 – – Robson staging 3, 57 – – TNM staging 3, 57 – Wilms tumor 354 prostate metastases 281 psammoma bodies 366
pseudoenhancement 33, 64, 160, 206 pseudotumor 53
– laparoscopic partial nephrectomy 416 R
radiofrequency (RF) ablation 59, 375–381 – background 375
– complications 379 – principle 376 – technique 377
renal cell carcinoma 103–123
– acquired cystic disease of the kidney 229 – angiography 110
– bilateral 234 – calcifi cation 231 – classifi cation 104 – clinical presentation 104 – CT 110
– cystic renal cell carcinoma 116, 227 – differential diagnosis 119
– fat 233
– genetic events 11 – hereditary disease 234 – histology 103 – incidence 103
– intravenous urography 106 – molecular events 11 – MR imaging 110 – multiloclar cystic 229 – multiple 234
– new trends in detection 104 – pediatric 358
– PET 116
– plain radiographs 105 – polycystic kidney disease 229 – renal sinus 195
– risk factors 104
– sarcomatoid differentiation 154 – small lesions 230
– spontaneous perirenal hemorrhage 121 – therapy 104
– ultrasound 107 – varicocele 235
renal lymphoma, see lymphoma renal metastases 273 – CT 42
– ultrasound 23
renal sinus neoplasms 187–201 – Castelman disease 333 – hemangiopericytoma 193 – Hodgkin disease 333 – imaging modalities 188 – leiomyosarcoma 193 – lymphoma 199, 333 – metastasis 200
– multilocular cystic nephroma 195 – renal cell carcinoma 195 – squamous cell carcinoma 190 – transitional cell carcinoma 189 renal vein thrombosis 113 rendering method 406 retrograde pyelography
– transitional cell carcinoma 128 rhabdoid tumor of the kidney (RTK) 152 – pediatric 357
rhabdomyosarcoma 150 Robson staging 3, 57, 104
S
sarcoma 145–157
– angiomyolipoma with sarcomatoid transformation 150 – angiosarcoma 152
– chondrosarcoma 153
– extraosseous Ewing sarcoma/primitive neuroectodermal tumor 154
– fi brosarcoma 153 – leiomyosarcoma 146 – liposarcoma 148
– malignant fi brous histiocytoma 153 – malignant hemangiopericytoma 152 – malignant mesenchymoma 153 – osteosarcoma 152
– rhabdomyosarcoma 150
– sarcomatoid differentiation of renal cell carcinoma 154 – – histopathology 8
sarcomatoid differentiation of renal cell carcinoma 154 – histopathology 225
scaffolding 340 sentinel cyst 118
sickle cell trait (SCT) 173, 223, 253, 359 signal-to-noise ratio (SNR) 52
single-shot fast spin echo (SSFSE) 61, 110 skeletal muscle metastases 298
skin metastases 298
small intestine metastases 278 small renal neoplasms 203–218 – biopsy 213
– CT 206
– – characteristics 211
– – multiphasic CT 209
– – pseudoenhancement 206
– – technical considerations 206
– fi ne-needle aspiration 213
– growth characteristics 204
small renal neoplasms (continued) – MR imaging 212
– pathology 203
– renal cell carcinoma 230 – – Doppler 16
– – intraoperative evaluation 26 – – ultrasound 16, 26
– treatment 215 – ultrasound 213 spinal cord metastases 288 splenic metastases 269
spontaneous regression of metastases 258 staghorn vascular pattern 152
staging
– MR imaging 56 – PET/CT 96
– renal cell carcinoma 112 – – pediatric 360
– transitional cell carcinoma 139 – Wilms tumor 354
standardized uptake value (SUV) 91 squamous cell carcinoma
– renal sinus 190
T
therapy
– renal cell carcinoma 104 – transitional cell carcinoma 140 thyroid gland metastases 296 TNM staging
– renal cell carcinoma 3, 43, 57, 105 – transitional cell carcinoma 140 transarterial embolization 385–395 – absolute ethanol 387
– bone metastases 391 – – complications 394 – – indications 391 – – results 394 – – technique 391
– calibrated microspheres 386 – complications 391
– cyanoacrylate 387 – gelatin sponge 386 – indications 388
– non-spherical polyvinyl alcohol particles 386 – procedures 388
– results 389 – survival 391 – symptom control 389 – technique 385
transitional cell carcinoma 125–143 – angiography 137
– CT 42, 132 – etiology 126 – follow-up 141 – incidence 125
– intravenous urography 127 – MR imaging 69, 137 – pathophysiology 126 – presentation 126 – renal sinus 189
– retrograde pyelography 128 – staging 139
– treatment 140 – ultrasound 128
translocation of chromosome 3 254 treatment
– collecting duct carcinoma 183 – small renal neoplasms 215 – transitional cell carcinoma 140 tris-acryl gelatin 386
tuberin 240
tuberous sclerosis 235 – clinical features 253 – genetics 253 – hamartin 240 – imaging 254 – management 254 – TSC1 254 – TSC2 254 – tuberin 240
U
ultrasound 15–28 – angiomyolipoma 22 – bleeding renal tumors 23 – collecting duct carcinoma 177 – complex cysts 24
– contrast agents 16
– cystic renal cell carcinoma 19 – detection of kidney cancer 15 – false hyperechoic tumors 21 – fetal lobations 22
– incidental detection 15
– inferior vena cava involvement 26 – intraoperative tumor evaluation 26 – lobar dysmorphism 22
– lymphoma 23, 323 – oncocytoma 22
– preoperative tumor staging 26 – pseudotumors 20
– renal cell carcinoma 17, 107 – renal metastases 23 – renal sinus neoplasms 188 – secondary renal neoplasms 23 – small renal neoplasms 16, 18, 213 – transitional cell carcinoma 128
Union Internationale Contre le Cancer (UICC) 104 unusual kidney cancers 219–238
– acquired cystic disease of the kidney 229 – bilateral renal cell carcinoma 234 – calcifi cations in renal cell carcinoma 231 – cyst-associated renal cell carcinoma 227 – cystic changes in renal cell carcinoma 227 – fatty component in renal cell carcinoma 233 – hereditary disease 234
– – tuberous sclerosis 235 – – von Hippel-Lindau disease 234
– multilocular cystic renal cell carcinoma 229 – multiple renal cell carcinoma 234
– pathology 219
– – avascular renal cell carcinoma 225
unusual kidney cancers (continued)
– – chromophobe cell renal cell carcinoma 221 – – classifi cation 219
– – clear cell renal cell carcinoma 220 – – collecting duct renal cell carcinoma 221 – – hypovascular renal cell carcinoma 225 – – infi ltrative growth pattern 225 – – medullary renal cell carcinoma 223 – – papillary renal cell carcinoma 221 – – sarcomatoid renal cell carcinoma 225 – polycystic kidney disease 229
– small renal cell carcinoma 230 – varicocele 235
Ulex europaeus agglutinin-I (UEA-I) 172, 175
V
varicocele 235 venous spread – CT 45
virtual display 406
virtual endoscopic imaging 408
volumetric interpolated breath-hold examination (VIBE) 63
von Hippel-Lindau disease 234, 359 – clinical features 241
– genetics 243
– hypoxia inducible factor- α (HIFα) 243 – imaging 243
– intraoperative evaluation 26 – management 243
– VHL gene 11, 243 W
WAGR 351
Waldenström macroglobulinemia 344 Wilms tumor 150, 198, 351
– bone metastases 317 – prognosis 354 – staging 354
World Health Organization (WHO) classifi cation 1 Wunderlich syndrome 365
X
xanthogranulomatous pyelonephritis (XGP) 121, 416
X-rays, see plain radiographs
List of Contributors
CMYK
Raid Abo-kamil, MD Research fellow Department of Surgery Division of Urology
University of Alabama School of Medicine at Birmingham
1530 3rd Avenue South, MEB 602 Birmingham, AL 35294-3296 USA
David W. Barker, MD Senior Radiologist
Tennessee Cancer Specialists, PLLC Medical Director
LifeCare Partners, LLC
1450 Dowell Springs Boulevard, Suite 230 Knoxville, TN 37909
USA
Emily D. Billingsley, MD Chief Resident
Department of Radiology
Louisiana State University Health Sciences Center 1542 Tulane Avenue
New Orleans, LA 70112 USA
Jocelyn A. S. Brookes, MRCP, FRCR Consultant Interventional Radiologist Department of Radiology
The Middlesex Hospital, UCLH Mortimer Street
London W1T 3AA, England UK
Ronan F. J. Browne , MD Fellow in Abdominal Imaging Abdominal Division
Department of Radiology Vancouver General Hospital 899 West 12th Avenue
Vancouver V5Z 1M9, British Columbia Canada
Jae Young Byun, MD Professor and Chairman Department of Radiology Kangnam St. Mary’s Hospital College of Medicine
The Catholic University of Korea 505 Banpo-Dong, Seocho-Ku Seoul 137-040
South Korea
Jung Ah Choi, MD, PhD
Instructor, Department of Radiology Seoul National University
Bundang Hospital College of Medicine 300 Gumi-dong
Bundang-gu, Seong Nam Gyeonggi-Do 463-707 South Korea
Jean-Michel Correas , MD, PhD Associate Professor and Vice-Chairman Department of Radiology
Necker University Hospital 149 rue de Sèvres
75743 Paris Cedex 15 France
Nancy S. Curry , MD
Professor of Radiology and Urology Department of Radiology
Medical University of South Carolina 169 Ashley Avenue
Charleston, SC 29425 USA
Rizk El-Galley, MB BCH, FRCS Associate Professor
Department of Surgery, Division of Urology University of Alabama School of Medicine at Birmingham
1530 3rd Avenue South
Birmingham, AL 35294-3296
USA
CMYK
Iman El-Hariry, MD, PhD Senior Director
Oncology Clinical Development
& Medical Affairs Glaxo Smith Kline R&D Greenford Road Greenford
Middlesex UB6 0HE, England UK
Elliot K. Fishman , MD, FACR Professor of Radiology and Oncology Johns Hopkins University School of Medicine Director, Diagnostic Radiology and Body CT Department of Radiology
Johns Hopkins Outpatient Center 601 North Caroline Street, Room 3254 Baltimore, MD 21287
USA
Takahiro Fujimori, MD, PhD Professor and Chairman
Department of Surgical and Molecular Pathology DOKKYO University School of Medicine
Director, Department of Surgical Pathology DOKKYO University Hospital
880 Kitakobayashi Mibu, Shimo-tsuga Tochigi 321-0293 Japan
Debra A. Gervais, MD
Assistant Professor of Radiology Harvard Medical School
Department of Radiology
Director of Interventional Radiology Division of Abdominal Imaging and Interventional Radiology Massachusetts General Hospital 55 Fruit Street
Boston, MA 02114 USA
Ali Guermazi, MD Senior Radiologist
Scientifi c Director, Oncology Services Department of Radiology Services Synarc Inc.
575 Market Street, 17th Floor San Francisco, CA 94105 USA
Peter F. Hahn, MD, PhD Associate Professor of Radiology Harvard Medical School
Department of Radiology Division of Abdominal Imaging and Interventional Radiology Massachusetts General Hospital 55 Fruit Street
Boston, MA 02114 USA
Olivier Hélénon, MD Professor and Chairman Department of Radiology Necker University Hospital 149 rue de Sèvres
75743 Paris Cedex 15 France
Gary M. Israel , MD Associate Professor
Department of Diagnostic Radiology Yale University School of Medicine PO Box 208042
333 Cedar Street
New Haven, CT 06520-8042 USA
Hisao Ito , MD
Professor and Chairman Department of Radiology Graduate School of Medicine Chiba University
1-8-1 Inohana, Chuoh-ku Chiba-city, Chiba 260-8670 Japan
Heung Sik Kang, MD, PhD Professor
Department of Radiology
President, Seoul National University Bundang Hospital
Seoul National University College of Medicine 300 Gumi-dong
Bundang-gu, Seong Nam
Gyeonggi-Do 463-707
South Korea
CMYK
Kyeong Ah Kim , MD Assistant Professor Department of Radiology Korea University Guro Hospital 97 Gurodong-Gil, Guro-Ku Seoul 152-703
South Korea
Lisa H. Lowe , MD, FAAP
Associate Professor of Pediatric Radiology Children’s Mercy Hospital and Clinics University of Missouri-Kansas City 2401 Gillham Road
Kansas City, MO 64108 USA
Yves Miaux, MD, MSc
Senior Vice President, Radiology Services Synarc Inc.
575 Market Street, 17th Floor San Francisco, CA 94105 USA
Toshiyuki Miyazaki, MD Chairman
Department of Radiology Arao City Hospital 2600 Arao
Arao city 864-0041 Japan
Peter R. Mueller, MD Professor of Radiology Harvard Medical School Department of Radiology Division Head
Division of Abdominal Imaging and Interventional Radiology Massachusetts General Hospital 55 Fruit Street
Boston, MA 02114 USA
Clara G.C. Ooi , MD
Associate Professor and Honorary Consultant Department of Diagnostic Radiology
Queen Mary Hospital University of Hong Kong
Pokfulam Road, Room 405, Block K Hong Kong SAR
China
Cheol Min Park, MD Professor
Department of Radiology Korea University Guro Hospital 97 Gurodong-Gil, Guro-Ku Seoul 152-703
South Korea
Uday Patel, MRCP, FRCR
Consultant Interventional Radiologist Department of Radiology
St George’s Hospital and Medical School Blackshaw Road
London SW17 0QT, England UK
Jean-Pierre Pelage , MD, PhD Associate Professor
Department of Radiology
Ambroise Paré University Hospital 9 avenue Charles de Gaulle 92104 Boulogne Billancourt France
E. Scott Pretorius, MD
Wallace T. Miller Sr. Chair of Radiologic Education Residency Program Training Director
MRI Section, Department of Radiology University of Pennsylvania Medical Center 1 Silverstein, 3400 Spruce Street
Philadelphia, PA 19104 USA
Salah Dine Qanadli, MD, PhD Associate Professor
Department of Radiology and Interventional Radiology
Centre Hospitalier Universitaire Vaudois (CHUV) 46 rue du Bugnon
1011 Lausanne Switzerland
Santiago Restrepo , MD Associate Professor of Radiology Vice Chairman of Research Department of Radiology
Louisiana State University Health Sciences Center 1542 Tulane Avenue
New Orleans, LA 70112
USA
CMYK
Seo Hee Rha , MD, PhD Associate Professor Department of Pathology
Dong-A University College of Medicine 1, 3-Ga, Dongdaesin-Dong, Seo-Gu Busan 602-715
South Korea
Sung Eun Rha , MD Assistant Professor Department of Radiology
Kangnam St. Mary’s Hospital College of Medicine The Catholic University of Korea
505 Banpo-Dong, Seocho-Ku Seoul 137-040
South Korea
Christiaan Schiepers , MD, PhD Professor
Department of Molecular and Medical Pharmacology
Professor
Department of Radiological Sciences David Geffen School of Medicine at UCLA 10833 Le Conte Avenue
AR-144 CHS
Los Angeles, CA 90095-6942 USA
Sheila Sheth , MD
Associate Professor of Radiology and Pathology Johns Hopkins University School of Medicine Director, Biopsy Service
Department of Radiology Johns Hopkins Hospital 600 North Wolfe Street HAL B176D
Baltimore, MD 21287 USA
Ajay K. Singh , MD
Clinical Instructor of Radiology Harvard Medical School Department of Radiology
Division of Emergency Radiology Massachusetts General Hospital 55 Fruit Street
Boston, MA 02114 USA
Eugenio M. Taboada , MD, FACP Assistant Professor of Pathology Director of Surgical Pathology Children’s Mercy Hospital and Clinics University of Missouri-Kansas City 2401 Gillham Road
Kansas City, MO 64108 USA
Mutsumasa Takahashi, MD Emeritus Professor
Department of Radiology Kumamoto University International Imaging Center 1-2-23 Kuhonji
Kumamoto city 862-0976 Japan
Shigeki Tomita, MD, PhD Assistant Professor of Pathology
Department of Surgical and Molecular Pathology DOKKYO University School of Medicine
Department of Surgical Pathology DOKKYO University Hospital
880 Kitakobayashi, Mibu, Shimo-tsuga Tochigi 321-0293
Japan
William C. Torreggiani, MD Consultant Radiologist
Department of Radiology Adelaide and Meath Hospital Tallaght
Dublin 24 Ireland
Takuya Ueda , MD
Faculty Radiologist, Teaching Stuff Department of Radiology
Graduate School of Medicine Chiba University 1-8-1 Inohana, Chuoh-ku
Chiba-city, Chiba 260-8670 Japan
Yoshihiko Ueda, MD, PhD Professor and Chairman Department of Pathology Koshigaya Hospital
DOKKYO University School of Medicine 2-1-50 Minami-Koshigaya, Koshigaya Saitama 343-8555
Japan
CMYK
